Natixis Advisors’s Cantel Medical Corporation CMD Stock Holding History

Natixis Advisors’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,623	Closed	-$1.09M	–	1348
2021 Q1	$1.09M	Buy	13,623 +129	+1%	+$10.1K	0.01%	1039
2020 Q4	$1.06M	Buy	13,494 +35	+0.3%	+$2.05K	0.01%	999
2020 Q3	$591K	Buy	13,459 +85	+0.6%	+$4.19K	﹤0.01%	1020
2020 Q2	$592K	Sell	13,374 -1,439	-10%	-$53.7K	﹤0.01%	1041
2020 Q1	$532K	Buy	+14,813	New	+$842K	﹤0.01%	1047

Natixis Advisors's CMD Position: Q2 2021 in Review

Natixis Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,623 shares — an estimated $1.09M sold.

Natixis Advisors first reported a position in CMD in Q1 2020 and held it in 5 quarters. The position peaked at $1.09M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Natixis Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Natixis Advisors sold 13,623 Cantel Medical Corporation shares in Q2 2021, an estimated $1.09M.
Natixis Advisors first reported a position in Cantel Medical Corporation in Q1 2020 and held it in 5 quarters.
Natixis Advisors's Cantel Medical Corporation position peaked at $1.09M in Q1 2021.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Natixis Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.